Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients
Background. Medullary thyroid cancer (MTC) is a rare neuroendocrine-derived malignancy. It is represented by sporadic and familiar forms, and both can have RET oncogene mutations. Numerous markers can be used to define MTC; however, none is generally approved for predicting the outcome of sporadic M...
Saved in:
Main Authors: | Raffaele Pezzani, Loris Bertazza, Elisabetta Cavedon, Simona Censi, Jacopo Manso, Sara Watutantrige-Fernando, Gianmaria Pennelli, Francesca Galuppini, Susi Barollo, Caterina Mian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2019/9421079 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma
by: Elisabetta Cavedon, et al.
Published: (2017-01-01) -
Sporadic Medullary Thyroid Carcinoma with Paraneoplastic Cushing Syndrome
by: Aleksandra I. Pivovarova, et al.
Published: (2019-01-01) -
Mixed Medullary-Follicular Carcinoma of the Thyroid
by: Maasumeh Tohidi, et al.
Published: (2013-01-01) -
Mixed Medullary and Follicular Thyroid Carcinoma (MMFTC)
by: Hasnaini Hasnaini, et al.
Published: (2020-11-01) -
Acute Liver Failure Secondary to Metastatic Medullary Thyroid Cancer
by: Emmanuel C. Gorospe, et al.
Published: (2011-01-01)